Epidermal growth factor inhibits rat pancreatic cell proliferation, causes acinar cell hypertrophy, and prevents caerulein-induced desensitization of amylase release - PubMed (original) (raw)

Epidermal growth factor inhibits rat pancreatic cell proliferation, causes acinar cell hypertrophy, and prevents caerulein-induced desensitization of amylase release

J Morisset et al. Endocrinology. 1989 Jun.

Abstract

The in vivo effects of epidermal growth factor (EGF) on pancreatic growth and digestive enzyme concentrations were compared with the actions of the pancreatic secretagogue caerulein in the adult rat. EGF (10 micrograms/kg BW) did not alter pancreatic weight or protein content. However, this concentration of EGF inhibited [3H]thymidine incorporation into DNA by 44%, decreased DNA content by 20%, and increased the concentrations of amylase, chymotrypsinogen, and protein by 106%, 232%, and 42%, respectively. Pancreatic acini prepared from EGF-treated rats exhibited a characteristic secretory response to caerulein that was superimposable to that obtained in acini from saline-treated rats. In both groups of acini half-maximal and maximal stimulation of amylase release occurred at approximately 5 pM and 50 pM caerulein, respectively. In contrast to EGF, caerulein (1 microgram/kg BW) increased pancreatic weight by 29% and protein content by 59%, and enhanced [3H]thymidine incorporation into DNA by 70%. Although caerulein increased the concentrations of pancreatic amylase and chymotrypsinogen by 38% and 297%, respectively, pancreatic acini prepared from caerulein-treated rats were less sensitive to the actions of caerulein in vitro when compared with acini from control rats. Indeed, the EC50 was shift from 4.8 pM to 9.8 pM after 4 days of treatment. EGF potentiated the actions of caerulein on pancreatic weight, protein content, and chymotrypsinogen concentration, and prevented the caerulein-induced alteration in the secretory responsiveness of the acinar cell. Conversely, caerulein reversed the inhibitory effect of EGF on thymidine incorporation. These findings suggest that EGF may modulate the trophic effects of certain gastrointestinal hormones, and may participate in the regulation of pancreatic exocrine function in vivo.

PubMed Disclaimer

Cited by

Alterations of pancreatic amylase secretion in the reserpinized rat model of cystic fibrosis. Effects of cerulein and EGF.
Morisset J, Bérubé FL, Vanier M, Benrezzak O. Morisset J, et al. Int J Pancreatol. 1994 Aug;16(1):37-44. doi: 10.1007/BF02925608. Int J Pancreatol. 1994. PMID: 7528761
Release and binding of epidermal growth factor in the pancreas of rats.
Jaworek J, Konturek SJ, Bielanski W, Bilski J, Hladij M. Jaworek J, et al. Int J Pancreatol. 1992 Feb;11(1):9-17. doi: 10.1007/BF02925987. Int J Pancreatol. 1992. PMID: 1583356
Epidermal growth factor receptor expression in pancreatic lesions induced in the rat by azaserine.
Visser CJ, de Weger RA, van Blokland WT, Seifert-Bock I, Kobrin MS, Korc M, Woutersen RA. Visser CJ, et al. Br J Cancer. 1996 Jul;74(1):92-8. doi: 10.1038/bjc.1996.321. Br J Cancer. 1996. PMID: 8679465 Free PMC article.

Epidermal growth factor inhibits rat pancreatic cell proliferation, causes acinar cell hypertrophy, and prevents caerulein-induced desensitization of amylase release - PubMed (original) (raw)